Drug shortages homepage
Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.
A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.
A discontinuation means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug, permanently ceases the sale of the drug.
Tier 3 drug shortages are those that have the greatest potential impact on Canada's drug supply and health care system. Impact is based on low availability of alternative supplies, ingredients or therapies. The Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders, makes recommendations on the tier assignment of drug shortages. The TAC assessment includes:
- a review of the information gathered on the shortage issue, and
- a thorough discussion on its potential impact and next steps.
Below are the newest and most recently updated Shortage and Discontinuation reports. Alternatively, please visit the Tier 3 page to see current Tier 3 Drug Shortages and associated shortage or discontinuation reports.

LEGEND
!!T3 denotes an actual Tier 3 shortage/discontinuation
!T3 denotes an anticipated Tier 3 shortage/discontinuation
Shortage Reports
Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
---|---|---|---|---|---|---|
APO-ROSUVASTATIN | APOTEX INC | Actual shortage | 40MG | Updated Report | 2023-03-23 | 187730 |
APO-AMIODARONE TABLETS | APOTEX INC | Actual shortage | 200MG | New Report | 2023-03-23 | 187727 |
APO-METHYLPHENIDATE | APOTEX INC | Actual shortage | 10MG | Updated Report | 2023-03-23 | 187724 |
APO-CITALOPRAM | APOTEX INC | Actual shortage | 40MG | Updated Report | 2023-03-23 | 187721 |
APO-LEVOCARB-TAB 25MG/100MG | APOTEX INC | Actual shortage | 100MG 25MG | New Report | 2023-03-23 | 187718 |
TRI-CIRA 28 | APOTEX INC | Actual shortage | 0.035MG 0.25MG 0.035MG 0.215MG 0.035MG 0.18MG | New Report | 2023-03-23 | 187715 |
APO-ALLOPURINOL | APOTEX INC | Actual shortage | 200MG | Updated Report | 2023-03-23 | 185028 |
APO-LEVETIRACETAM | APOTEX INC | Actual shortage | 750MG | Updated Report | 2023-03-23 | 183477 |
APO-OXYBUTYNIN | APOTEX INC | Actual shortage | 5MG | Updated Report | 2023-03-23 | 183474 |
APO-OXYBUTYNIN | APOTEX INC | Actual shortage | 5MG | Updated Report | 2023-03-23 | 187229 |
APO-DICLO | APOTEX INC | Actual shortage | 50MG | Updated Report | 2023-03-23 | 182361 |
APO-SITAGLIPTIN/METFORMIN XR | APOTEX INC | Actual shortage | 1000MG 100MG | Updated Report | 2023-03-23 | 185985 |
APO-VENLAFAXINE XR | APOTEX INC | Actual shortage | 150MG | Updated Report | 2023-03-23 | 165727 |
APO-VENLAFAXINE XR | APOTEX INC | Actual shortage | 150MG | Updated Report | 2023-03-23 | 178766 |
TRI-CIRA LO 21 | APOTEX INC | Actual shortage | 0.025MG 0.25MG 0.025MG 0.215MG 0.025MG 0.18MG | Updated Report | 2023-03-23 | 172942 |
APO-PRAMIPEXOLE | APOTEX INC | Actual shortage | 0.25MG | Updated Report | 2023-03-23 | 183483 |
APO-SUCRALFATE - TAB 1G | APOTEX INC | Actual shortage | 1G | Updated Report | 2023-03-23 | 169045 |
OVIMA 28 | APOTEX INC | Resolved | 30MCG 150MCG | Updated Report | 2023-03-23 | 185933 |
APO-SERTRALINE | APOTEX INC | Resolved | 50MG | Updated Report | 2023-03-23 | 185004 |
APO-MONTELUKAST | APOTEX INC | Actual shortage | 10MG | Updated Report | 2023-03-23 | 187241 |
Discontinuation Reports
Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
---|---|---|---|---|---|---|
QUININE - ODAN | ODAN LABORATORIES LTD | Discontinued | 200MG | New Report | 2023-03-22 | 187637 |
FLAGYL | ODAN LABORATORIES LTD | Discontinued | 500MG | New Report | 2023-03-22 | 187634 |
NOLVADEX-D TAB 20MG | ASTRAZENECA CANADA INC | Discontinued | 20MG | Updated Report | 2023-03-22 | 170947 |
OMNIPAQUE 240 | GE HEALTHCARE CANADA INC | Discontinued | 518MG | Updated Report | 2023-03-18 | 182760 |
GLUCAGON | ELI LILLY CANADA INC | To be discontinued | 1MG | Updated Report | 2023-03-14 | 165759 |